• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327

Recent Advances in the Application of 2-(Methoxycarbonyl)thiophene-3-carboxylic acid (CAS: 115777-72-5) in Chemical Biology and Pharmaceutical Research

2-(Methoxycarbonyl)thiophene-3-carboxylic acid (CAS: 115777-72-5) is a thiophene-based carboxylic acid derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various bioactive molecules, including potential drug candidates. Recent studies have explored its utility in the development of novel therapeutic agents, particularly in the areas of anti-inflammatory, antimicrobial, and anticancer drug discovery.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 2-(Methoxycarbonyl)thiophene-3-carboxylic acid as a building block for the synthesis of novel COX-2 inhibitors with improved selectivity profiles. The researchers utilized this compound to develop a series of thiophene-based derivatives that showed potent anti-inflammatory activity with reduced gastrointestinal side effects compared to traditional NSAIDs. The study highlighted the importance of the methoxycarbonyl group in modulating the pharmacokinetic properties of the final compounds.

In the field of antimicrobial research, a recent publication in Bioorganic & Medicinal Chemistry Letters (2024) reported the development of new antibacterial agents incorporating 2-(Methoxycarbonyl)thiophene-3-carboxylic acid as a core structural element. The synthesized compounds exhibited promising activity against multidrug-resistant Gram-positive bacteria, with MIC values in the low micromolar range. Molecular docking studies suggested that these derivatives interfere with bacterial cell wall biosynthesis by targeting key enzymes in the peptidoglycan synthesis pathway.

Significant progress has also been made in cancer research applications. A 2024 study in the European Journal of Medicinal Chemistry described the design and synthesis of novel kinase inhibitors using 2-(Methoxycarbonyl)thiophene-3-carboxylic acid as a starting material. The resulting compounds demonstrated potent inhibitory activity against several cancer-associated kinases, including EGFR and VEGFR-2, with IC50 values below 100 nM in enzymatic assays. In vitro studies showed promising antiproliferative effects against various cancer cell lines, particularly in breast and lung cancer models.

Recent advances in synthetic methodology have expanded the utility of this compound. A 2023 publication in Organic Letters presented a novel, high-yielding synthetic route to 2-(Methoxycarbonyl)thiophene-3-carboxylic acid that significantly reduces production costs while maintaining excellent purity. This development is particularly important for scaling up production for pharmaceutical applications. The new method employs a one-pot, metal-free approach that is more environmentally friendly than traditional synthetic routes.

From a drug delivery perspective, researchers have recently explored the potential of 2-(Methoxycarbonyl)thiophene-3-carboxylic acid in prodrug design. A 2024 study in Molecular Pharmaceutics demonstrated how this compound can be conjugated to various drug molecules to improve their solubility and bioavailability. The carboxylic acid functionality allows for easy conjugation to drug molecules through ester or amide linkages, while the thiophene ring contributes to favorable pharmacokinetic properties.

Looking forward, the unique structural features of 2-(Methoxycarbonyl)thiophene-3-carboxylic acid continue to inspire new research directions. Current investigations are exploring its potential in targeted drug delivery systems, where the compound serves as a linker between therapeutic agents and targeting moieties. Additionally, its application in the development of fluorescent probes for biological imaging is an emerging area of interest, leveraging the inherent photophysical properties of the thiophene scaffold.

• 53229-46-2(Diethyl thiophene-2,3-dicarboxylate)
• 6007-83-6(Thieno2,3-cfuran-4,6-dione)
• 57041-28-8(2-Thiophenecarboxylic acid, 3,5-dimethyl-, methyl ester)
• 81452-54-2(Methyl 3-methylthiophene-2-carboxylate)
• 14300-68-6(dimethyl thiophene-2,3-dicarboxylate)
• 33668-06-3(2-Thiophenecarboxylic acid, 3,4-dimethyl-, methyl ester)
• 61206-94-8(2,3-Thiophenedicarboxylic acid, 4-phenyl-, dimethyl ester)
• 6520-81-6(2,4-Thiophenedicarboxylic acid, dimethyl ester)
• 799283-87-7(4-(Ethoxycarbonyl)-3-methylthiophene-2-carboxylic acid)
• 24647-82-3(Methyl 2-formylthiophene-3-carboxylate)